Suppr超能文献

结直肠肝转移首次切除术后复发的挽救性治疗:组织病理学生长模式的影响。

Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns.

机构信息

Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.

Department of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.

出版信息

Clin Exp Metastasis. 2019 Apr;36(2):109-118. doi: 10.1007/s10585-019-09960-7. Epub 2019 Mar 6.

Abstract

The majority of patients recur after resection of colorectal liver metastases (CRLM). Patients with CRLM displaying a desmoplastic histopathological growth pattern (dHGP) have a better prognosis and lower probability of recurrence than patients with non-dHGP CRLM. The current study evaluates the impact of HGP type on the pattern and treatment of recurrences after first resection of CRLM. A retrospective cohort study was performed, including patients with known HGP type after complete resection of CRLM. All patients were treated between 2000 and 2015. The HGP was determined on the CRLM resected at first partial hepatectomy. The prognostic value of HGPs, in terms of survival outcome, in the current patient cohort were previously published. In total 690 patients were included, of which 492 (71%) developed recurrent disease. CRLM displaying dHGP were observed in 103 patients (21%). Amongst patients with dHGP CRLM diagnosed with recurrent disease, more liver-limited recurrences were seen (43% vs. 31%, p = 0.030), whereas patients with non-dHGP more often recurred at multiple locations (34% vs. 19%, p = 0.005). Patients with dHGP CRLM were more likely to undergo curatively intended local treatment for recurrent disease (adjusted odds ratio: 2.37; 95% confidence interval (CI) [1.46-3.84]; p < 0.001) compared to patients with non-dHGP. The present study demonstrates that liver-limited disease recurrence after complete resection of CRLM is more often seen in patients with dHGP, whereas patients with non-dHGP more frequently experience multi-organ recurrence. Recurrences in patients with dHGP at first CRLM resection are more likely to be salvageable by local treatment modalities, but no prognostic impact of HGPs after salvage therapy for recurrent disease was found.

摘要

大多数结直肠癌肝转移(CRLM)患者在手术后会复发。与非促结缔组织增生型(dHGP)CRLM 患者相比,具有促结缔组织增生型(dHGP)组织病理学生长模式的 CRLM 患者具有更好的预后和更低的复发概率。本研究评估了 HGP 类型对首次 CRLM 切除后复发模式和治疗的影响。本研究进行了一项回顾性队列研究,纳入了 CRLM 完全切除后已知 HGP 类型的患者。所有患者均在 2000 年至 2015 年期间接受治疗。在首次部分肝切除时切除 CRLM 以确定 HGP。HGPs 的预后价值(就生存结果而言)在之前的患者队列中已有报道。共纳入 690 例患者,其中 492 例(71%)发生复发疾病。在 103 例(21%)患者中观察到 dHGP 型 CRLM。在诊断为复发疾病的 dHGP CRLM 患者中,更多的是肝脏局限性复发(43%比 31%,p=0.030),而非 dHGP 患者更多地发生多处复发(34%比 19%,p=0.005)。与非 dHGP 患者相比,dHGP CRLM 患者更有可能对复发性疾病进行有治愈意图的局部治疗(调整后的优势比:2.37;95%置信区间[1.46-3.84];p<0.001)。本研究表明,在完全切除 CRLM 后,肝脏局限性疾病复发更常见于 dHGP 患者,而非 dHGP 患者更常发生多器官复发。首次 CRLM 切除时 dHGP 患者的复发更有可能通过局部治疗方式挽救,但未发现 HGPs 对复发性疾病的挽救治疗后有预后影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5f/6445820/b115af1b648d/10585_2019_9960_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验